article thumbnail

Australia’s Reversal of its DABUS decision on AI-Generated Inventions: How Does this Impact an Imminent Canadian Discussion on AI Inventorship?

IPilogue

Previously, the Federal Court of Australia ruled that Australian patent law did not preclude “non-human” inventors from owning patents over their creations because no mental state of an inventor is required for an invention. What Does This Mean in the Canadian Context? In Apotex Inc v Wellcome Foundation.,

Invention 111
article thumbnail

Can AI Technology Create a Patent in Canada? A Look at Global Precedence

IPilogue

However, this 2002 decision did not define whether AI technology can be an inventor. Justice Marcus Smith explained his reasoning by saying that the meaning of the word “inventor” is limited to people under UK patent law. Canada: Apotex Inc v Wellcome Foundation Ltd [2002] 4 SCR 153.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

On Sale Bar – Sales require Consideration, not necessarily Money Payment

Patently-O

2022) focuses on the classic patent law question of whether the inventor’s pre-filing sales activity serve to bar the patent from issuing. Application of the on sale bar is a question of law as is the underlying issue of whether the experimental use exception applies. 2002) quoting Group One, Ltd.

article thumbnail

Considerations For Applicants and Practitioners Due to Recent EPC Guidelines Regarding Description Amendment Rrequirements

IP Intelligence

Article 84 of the European Patent Convention (EPC) requires that the claims of a European patent application “shall define the matter for which protection is sought” and “shall be clear and concise and be supported by the description.”[i] application; and (d) “relevant and not related to unique aspects of foreign patent law.”[xi].

article thumbnail

Patenting Biotech Invention

Biswajit Sarkar Copyright Blog

Initially, laws relating to patents in India did not cover inventions related to biotechnology until an amendment in 2002 acknowledged biotechnological, biochemical and microbiological processes as having the potential to be patented. whether or not these are part of the subject matter of a patentable innovation.

article thumbnail

Evergreening of Patents

Kashishipr

In 2002, the Federal Trade Commission, after an extensive inquiry, found out that over 75% of applications by generic pharmaceutical manufacturers were in some way or other involved in litigation initiated by the original patent holders. India changed its Patents Laws in 2005 to comply with the TRIPS Agreement.

Patent 105
article thumbnail

Within The Scope of This Concise Analysis, the Case of Bajaj Auto Ltd. v. T.V.S. Motor Company Ltd. Is Investigated

IP and Legal Filings

The court has noted several factors that support the Applicants’ position. Since the tentative specification date in 2002, the Respondent has refrained from expressing any objections, even subsequent to the launch of the product (Bajaj Pulsar motorbike) onto the market. The idea of presuming the validity of a patent.